PharmaShots | Incisive News in 3 Shots

Subscribe Now

OncoC4

OncoC4 Reports the First Patient Dosing in P-I Study of ONC-841 for Solid Tumors

OncoC4 Reports the First Patient Dosing in P-I Study of ONC-841 for Solid Tumors

September 5, 2024

OncoC4 Reports First Patient Dosing of ONC-392 + Keytruda (pembrolizumab) in P-II Study (PRESERVE-004) for Platinum-Resistant Ovarian Cancer

OncoC4 Reports First Patient Dosing of ONC-392 + Keytruda (pembrolizumab) in P-II Study (PRESERVE-004) for Platinum-Resistant Ovar...

January 2, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us